Jun gong Zhao

Jun gong Zhao


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2022 in Quantitative Imaging in Medicine and Surgery
Verified
Journal Article
Open access
PDF file
LHLei Hu
Lei Hu
DZDa-Wei Zhou
Da-Wei Zhou
XGXiang-Yu Guo
Xiang-Yu Guo
WXWen-Hao Xu
Wen-Hao Xu
LWLi-Ming Wei
Li-Ming Wei
JZJun gong Zhao
Jun gong Zhao
Original Article Adversarial training for prostate cancer classification using magnetic resonance imaging Lei Hu, Da-Wei Zhou, Xiang-Yu Guo, Wen-Hao Xu, Li-Ming Wei, Jun-Gong Zhao

1 September 2021 in Radiology: Artificial Intelligence
Verified
Journal Article
Closed access
LHLei Hu
Lei Hu
DZDa-Wei Zhou
Da-Wei Zhou
YZYunfei Zha
Yunfei Zha
LLLiang Li
Liang Li
HHHuan He
Huan He
JZJun gong Zhao
Jun gong Zhao
“Just Accepted” papers have undergone full peer review and have been accepted for publication in Radiology: Artificial Intelligence. This article will undergo copyediting, layout, and proof review ...

16 September 2020 in European Radiology
Verified
Journal Article
Closed access
PDF file
LHLei Hu
Lei Hu
DZDa Wei Zhou
Da Wei Zhou
CFCai Xia Fu
Cai Xia Fu
TBThomas Benkert
Thomas Benkert
CJChun Yu Jiang
Chun Yu Jiang
JZJun gong Zhao
Jun gong Zhao

3 May 2021 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
CJChunyu Jiang
Chunyu Jiang
RLRuiting Li
Ruiting Li
CXChaoyang Xiu
Chaoyang Xiu
XMXu Ma
Xu Ma
HHHui Hu
Hui Hu
JZJun gong Zhao
Jun gong Zhao
Background: Endothelial progenitor cell (EPC) dysfunction contributes to vascular disease in diabetes mellitus. However, the molecular mechanism underlying EPC dysfunction and its contribution to delayed reendothelialization in diabetes mellitus remain unclear. Our study aimed to illustrate the potential molecular mechanism underlying diabetic EPC dysfunction in vivo and in vitro. Furthermore, we assessed the effect of EPC transplantation on endothelial regeneration in diabetic rats.Methods: Late outgrowth EPCs were isolated from the bone marrow of rats for in vivo and in vitro studies. In vitro functional assays and Western blotting were conducted to reveal the association between C-X-C chemokine receptor type 7 (CXCR7) expression and diabetic EPC dysfunction. To confirm the association between cellular CXCR7 levels and EPC function, CXCR7 expression in EPCs was upregulated and downregulated via lentiviral transduction and RNA interference, respectively. Western blotting was used to reveal the potential molecular mechanism by which the Stromal-Derived Factor-1 (SDF-1)/CXCR7 axis regulates EPC function. To elucidate the role of the SDF-1/CXCR7 axis in EPC-mediated endothelial regeneration, a carotid artery injury model was established in diabetic rats. After the model was established, saline-treated, diabetic, normal, or CXCR7-primed EPCs were injected via the tail vein.Results: Diabetic EPC dysfunction was associated with decreased CXCR7 expression. Furthermore, EPC dysfunction was mimicked by knockdown of CXCR7 in normal EPCs. However, upregulating CXCR7 expression reversed the dysfunction of diabetic EPCs. The SDF-1/CXCR7 axis positively regulated EPC function by activating the AKT-associated Kelch-like ECH-associated protein 1 (keap-1)/nuclear factor erythroid 2-related factor 2 (Nrf2) axis, which was reversed by blockade of AKT and Nrf2. Transplantation of CXCR7-EPCs accelerated endothelial repair and attenuated neointimal hyperplasia in diabetes mellitus more significantly than transplantation of diabetic or normal EPCs. However, the therapeutic effect of CXCR7-EPC transplantation on endothelial regeneration was reversed by knockdown of Nrf2 expression.Conclusions: Dysfunction of diabetic EPCs is associated with decreased CXCR7 expression. Furthermore, the SDF-1/CXCR7 axis positively regulates EPC function by activating the AKT/keap-1/Nrf2 axis. CXCR7-primed EPCs might be useful for endothelial regeneration in diabetes-associated vascular disease.

17 January 2023 in Cancer Imaging
Verified
Journal Article
Open access
PDF file
LHLei Hu
Lei Hu
CFCaixia Fu
Caixia Fu
XSXinyang Song
Xinyang Song
RGRobert Grimm
Robert Grimm
HBHeinrich von Busch
Heinrich von Busch
JZJun gong Zhao
Jun gong Zhao
Background: Deep-learning-based computer-aided diagnosis (DL-CAD) systems using MRI for prostate cancer (PCa) detection have demonstrated good performance. Nevertheless, DL-CAD systems are vulnerable to high heterogeneities in DWI, which can interfere with DL-CAD assessments and impair performance. This study aims to compare PCa detection of DL-CAD between zoomed-field-of-view echo-planar DWI (z-DWI) and full-field-of-view DWI (f-DWI) and find the risk factors affecting DL-CAD diagnostic efficiency. Methods: This retrospective study enrolled 354 consecutive participants who underwent MRI including T2WI, f-DWI, and z-DWI because of clinically suspected PCa. A DL-CAD was used to compare the performance of f-DWI and z-DWI both on a patient level and lesion level. We used the area under the curve (AUC) of receiver operating characteristics analysis and alternative free-response receiver operating characteristics analysis to compare the performances of DL-CAD using f- DWI and z-DWI. The risk factors affecting the DL-CAD were analyzed using logistic regression analyses. P values less than 0.05 were considered statistically significant. Results: DL-CAD with z-DWI had a significantly better overall accuracy than that with f-DWI both on patient level and lesion level (AUCpatient: 0.89 vs. 0.86; AUClesion: 0.86 vs. 0.76; P < .001). The contrast-to-noise ratio (CNR) of lesions in DWI was an independent risk factor of false positives (odds ratio [OR] = 1.12; P < .001). Rectal susceptibility artifacts, lesion diameter, and apparent diffusion coefficients (ADC) were independent risk factors of both false positives (ORrectal susceptibility artifact = 5.46; ORdiameter, = 1.12; ORADC = 0.998; all P < .001) and false negatives (ORrectal susceptibility artifact = 3.31; ORdiameter = 0.82; ORADC = 1.007; all P ≤ .03) of DL-CAD. Conclusions: Z-DWI has potential to improve the detection performance of a prostate MRI based DL-CAD. Trial registration: ChiCTR, NO. ChiCTR2100041834. Registered 7 January 2021.

12 September 2021 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
LHLei Hu
Lei Hu
LWLiming Wei
Liming Wei
SWShuhao Wang
Shuhao Wang
CFCaixia Fu
Caixia Fu
TBThomas Benker
Thomas Benker
JZJun gong Zhao
Jun gong Zhao